US 11713461
Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors
granted A61PA61P19/08A61P19/10
Quick answer
US patent 11713461 (Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P19/08, A61P19/10